Cramer on OxyContin maker Purdue filing $10 billion plan to exit bankruptcy

Purdue Pharma, which helped revolutionize the prescription painkiller business with its drug OxyContin, is proposing a $10 billion plan to emerge from bankruptcy that calls for it to be transformed into a different kind of company funneling profits into the fight against the nation’s intractable opioid crisis. CNBC's Jim Cramer, Carl Quintanilla and David Faber discuss.